Bioporto A/S - ESG Rating & Company Profile powered by AI
The dashboard contains a Q&A section about Bioporto A/S. The ESG rating for Bioporto A/S indicates the company's reporting of the UN SDGs. Other corporations in the rating peer group for Bioporto A/S are shown below.
Bioporto A/S in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.1; made up of an environmental score of 2.7, social score of 1.6 and governance score of 8.0.
4.1
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
969 | Vertex Pharmaceuticals Inc | 4.2 | High |
969 | Zentalis Pharmaceuticals Inc | 4.2 | High |
989 | Bioporto A/S | 4.1 | High |
989 | Advanz Pharma Corp Ltd | 4.1 | High |
989 | Abeona Therapeutics Inc | 4.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Bioporto A/S have an accelerator or VC vehicle to help deliver innovation?
Does Bioporto A/S disclose current and historical energy intensity?
Does Bioporto A/S report the average age of the workforce?
Does Bioporto A/S reference operational or capital allocation in relation to climate change?
Does Bioporto A/S disclose its ethnicity pay gap?
Does Bioporto A/S disclose cybersecurity risks?
Does Bioporto A/S offer flexible work?
Does Bioporto A/S have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Bioporto A/S disclose the number of employees in R&D functions?
Does Bioporto A/S conduct supply chain audits?
Does Bioporto A/S disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Bioporto A/S conduct 360 degree staff reviews?
Does Bioporto A/S disclose the individual responsible for D&I?
Does Bioporto A/S disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Bioporto A/S disclose current and / or historical scope 2 emissions?
Does Bioporto A/S disclose water use targets?
Does Bioporto A/S have careers partnerships with academic institutions?
Did Bioporto A/S have a product recall in the last two years?
Does Bioporto A/S disclose incidents of discrimination?
Does Bioporto A/S allow for Work Councils/Collective Agreements to be formed?
Has Bioporto A/S issued a profit warning in the past 24 months?
Does Bioporto A/S disclose parental leave metrics?
Does Bioporto A/S disclose climate scenario or pathway analysis?
Does Bioporto A/S disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Bioporto A/S disclose the pay ratio of women to men?
Does Bioporto A/S support suppliers with sustainability related research and development?
Does Bioporto A/S disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Bioporto A/S reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Bioporto A/S involved in embryonic stem cell research?
Does Bioporto A/S disclose GHG and Air Emissions intensity?
Does Bioporto A/S disclose its waste policy?
Does Bioporto A/S report according to TCFD requirements?
Does Bioporto A/S disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Bioporto A/S disclose energy use targets?
Does Bioporto A/S disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Bioporto A/S have a policy relating to cyber security?
Have a different question?
Potential Risks for Bioporto A/S
These potential risks are based on the size, segment and geographies of the company.
BioPorto A/S, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company offers the neutrophil gelatinase-associated lipocalin test, a particle-enhanced turbidimetric test that measures NGAL that is used to supplement clinical evaluation and standard tests; monoclonal antibodies for scientific, pharmaceutical, and clinical research use; enzyme-linked immunosorbent assay kits; IVD automated assays; and generic rapid assay device platform for the development of lateral flow assays. It sells its products through own sales team, distributors, and OEM partnerships. The company was founded in 2000 and is headquartered in Hellerup, Denmark.